Transmural dispersion of repolarization and arrhythmogenicity: The Brugada syndrome versus the long QT syndrome

Journal of Electrocardiology

Volumn 32, Issue SUPPL., 1999, Pages 158-165

  Antzelevitch, Charles ^a   Yan, Gan Xin ^a   Shimizu, Wataru ^a  

^a MASONIC MEDICAL RESEARCH LABORATORY   (United States)

Author keywords

Cardiac arrythmias; Heterogeneity; Long QT syndrome; M cells; Ventricular fibrillation; Ventricular tachycardia

Indexed keywords

ION CHANNEL;

ACTION POTENTIAL; ARRHYTHMOGENESIS; BRUGADA SYNDROME; CONFERENCE PAPER; ELECTROCARDIOGRAM; ELECTROPHYSIOLOGY; EPICARDIUM; EXTRASYSTOLE; HEART MUSCLE ISCHEMIA; HEART REPOLARIZATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; LONG QT SYNDROME; PRIORITY JOURNAL; ST SEGMENT ELEVATION; T WAVE; TORSADE DES POINTES;

EID: 0033379061     PISSN: 00220736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-0736(99)90074-2     Document Type: Conference Paper

References (49)

1. Schwartz PJ, Periti M, Malliani A: The long QT syndrome. Am Heart J 89:378, 1975
2. Moss AJ, Schwartz PJ, Crampton RS, et al: The long QT syndrome: a prospective international study. Circulation 71:17, 1985
3. Zipes DP: The long QT interval syndrome: a Rosetta stone for sympathetic related ventricular tachyarrhythmias. Circulation 84:1414, 1991
4. Shimizu W, Ohe T, Kurita T, et al: Effects of verapamil and propranolol on early afterdepolarizations and ventricular arrhythmias induced by epinephrine in congenital long QT syndrome. J Am Coll Cardiol 26:1299, 1995
5. Roden DM, Lazzara R, Rosen MR, et al: Multiple mechanisms in the long-QT syndrome: current knowledge, gaps, and future directions. Circulation 94:1996, 1996
6. Antzelevitch C, Sun ZQ, Zhang ZQ, Yan GX: Cellular and ionic mechanisms underlying erythromydn-induced long QT and torsade de pointes. J Am Coll Cardiol 28:1836, 1996
7. Shimizu W, Antzelevitch C: Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade de pointes in LQT2 and LQT3 models of the long-QT syndrome. Circulation 96:2038, 1997
8. Shimizu W, Antzelevitch C: Cellular basis for the electrocardiographic features of the LQT1 form of the long QT syndrome: effects of β-adrenergic agonists, antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes. Circulation 98:2314, 1998
9. Yan GX, Shimizu W, Antzelevitch C: Characteristics and distribution of M cells in arterially-perfused canine left ventricular wedge preparations. Circulation 98:1921, 1998
10. Yan GX, Antzelevitch C: Cellular basis for the normal T wave and the electrocardiographic manifestations of the long QT syndrome. Circulation 98:1928, 1998
11. Shimizu W, Antzelevitch C: Cellular and ionic basis for T wave alternans under long QT conditions. Circulation 99:1499, 1999
12. Shimizu W, Antzelevitch C: Characteristics of spontaneous as well as stimulation-induced torsade de pointes in LQT2 and LQT3 models of the long QT syndrome (abstract). Circulation 96:1-554, 1997
13. Schwartz PJ: The idiopathic long QT syndrome: progress and questions. Am Heart J 109:399, 1985
14. Moss AJ, Schwartz PJ, Crampton RS, et al: The long QT syndrome: prospective longitudinal study of 328 families. Circulation 84:1136, 1991
15. Crampton RS: Preeminence of the left stellate ganglion in the long Q-T syndrome. Circulation 59:769, 1979
16. Timothy KW, Zhang L, Meyer KJ, Vincent GM: Differences in precipitators of cardiac arrest and sudden death in chromosome 11 versus 7 genotype long QT syndrome patients (abstract). Circulation 94:1-204, 1996
17. Ali RH, Zareba W, Rosero SZ, et al: Adrenergic triggers and non-adrenergic factors associated with cardiac events in long QT syndrome patients (abstract). Pacing Clin Electrophysiol 20:1072, 1997
18. Schwartz PJ, Malteo PS, Moss AJ, et al: Gene-specific influence on the triggers for cardiac arrest in the long QT syndrome (abstract). Circulation 96:1-212, 1997
19. Shimizu W, Antzelevitch C: Differential effects of β-adrenergic agonists and antagonists on transmural dispersion of repolarization and torsade de pointes in LQT1, LQT2 and LQT3 models of the long QT syndrome (abstract). Circulation 98:1-10, 1998
20. Eddlestone GT, Zygmunt AC, Antzelevitch C: Larger late sodium current contributes to the longer action potential of the M cell in canine ventricular myocardium (abstract). Pacing Clin Electrophysiol 19:11-569, 1996
21. Antzelevitch C, Sicouri S: Clinical relevance of cardiac arrhythmias generated by afterdepolarizations: the role of M cells in the generation of U waves, triggered activity and torsade de pointes. J Am Coll Cardiol 23:259, 1994
22. El-Sherif N, Caref EB, Yin H, Restivo M: The electrophysiological mechanism of ventricular arrhythmias in the long QT syndrome: tridimensional mapping of activation and recovery patterns. Circ Res 79:474, 1996
23. El-Sherif N, Chinushi M, Caref EB, Restivo M: Electrophysiological mechanism of the characteristic electrocardiographic morphology of torsade de pointes tachyarrhythmias in the long-QT syndrome. Detailed analysis of ventricular tridimensional activation patterns. Circulation 96:4392, 1997
24. Akar FG, Yan GX, Antzelevitch C, Rosenbaum DS: Optical maps reveal reentrant mechanism of torsade de pointes based on topography and electrophysiology of mid-myocardial cells (abstract). Circulation 96(8):I-355, 1997
25. Brugada P, Brugada J: Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome: a multicenter report. J Am Coll Cardiol 20:1391, 1992
26. Brugada P, Brugada J: A distinct clinical and electrocardiographic syndrome: right bundle branch block, persistent ST segment elevation with normal QT interval and sudden cardiac death (abstract). Pacing Clin Electrophysiol 14:746, 1991
27. Brugada J, Brugada P: Further characterization of the syndrome of right bundle branch block, ST segment elevation, and sudden cardiac death. J Cardiovasc Electrophysiol 8:325, 1997
28. 3. A marker for sudden death in patients without demonstrable structural heart disease. Circulation 97:457, 1998
29. Aizawa Y, Tamura M, Chinushi M, et al: Idiopathic ventricular fibrillation and bradycardia-dependent intraventricular block. Am Heart J 126:1473, 1993
30. Aizawa Y, Tamura M, Chinushi M, et al: An attempt at electrical catheter ablation of the arrhythmogenic area in idiopathic ventricular fibrillation. Am Heart J 123:257, 1992
31. Bjerregaard P, Gussak I, Kotar SI, Gessler JE: Recurrent synocope in a patient with prominent J-wave. Am Heart J 127:1426, 1994
32. Martini B, Nava A, Thiene G, et al: Ventricular fibrillation without apparent heart disease: description of six cases. Am Heart J 118:1203, 1989
33. Miyazaki T, Mitamura H, Miyoshi S, et al: Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol 27:1061, 1996
34. Kasanuki H, Ohnishi S, Ohtuka M, et al: Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease. Circulation 95:2277, 1997
35. Nademanee K: Sudden unexplained death syndrome in southeast Asia. Am J Cardiol 79(6A):10, 1997
36. Marcus FI: Idiopathic ventricular fibrillation. J Cardiovasc Electrophysiol 8:1075, 1997
37. Gussak I, Antzelevitch C, Bjerregaard P, et al: The Brugada syndrome: clinical, electrophysiological and genetic aspects. J Am Coll Cardiol 33:5, 1999
38. Corrado D, Nava A, Buja G, et al: Familial cardiomyopathy underlies syndrome of right bundle branch block, ST segment elevation and sudden death [see comments]. J Am Coll Cardiol 27:443, 1996
39. Ahmed F, Li D, Karibe A, et al: Localization of a gene responsible for arrhythmogenic right ventricular dysplasia to chromosome 3p23. Circulation 98:2791, 1998
40. Chen Q, Kirsch GE, Zhang D, et al: Genetic basis and molecular mechanisms for idiopathic ventricular fibrillation. Nature 392:293, 1997
41. Antzelevitch C: The Brugada syndrome. J Cardiovasc Electrophysiol 9:513, 1998
42. Yan GX, Antzelevitch C: Cellular basis for the Brugada syndrome. Circulation (in press)
43. Lukas A, Antzelevitch C: Phase 2 reentry as a mechanism of initiation of circus movement reentry in canine epicardium exposed to simulated ischemia. The antiarrhythmic effects of 4-aminopyridine. Cardiovasc Res 32:593, 1996
44. Di Diego JM, Antzelevitch C: Pinacidil-induced electrical heterogeneity and extrasystolic activity in canine ventricular tissues: does activation of ATP-regulated potassium current promote phase 2 reentry? Circulation 88:1177, 1993
45. Krishnan SC, Antzelevitch C: Flecainide-induced arrhythmia in canine ventricular epicardium: phase 2 reentry? Circulation 87:562, 1993
46. 2+] -induced electrical heterogeneity and extrasystolic activity in isolated canine ventricular epicardium: phase 2 reentry. Circulation 89:1839, 1994
47. Antzelevitch C, Sicouri S, Lukas A, et al: Clinical implications of electrical heterogeneity in the heart: the electrophysiology and pharmacology of epicardial, M and endocardial cells, p. 88. In Podrid PJ, Kowey PR (eds): Cardiac arrhythmia: mechanism, diagnosis and management. William & Wilkins, Baltimore, 1995
48. Antzelevitch C, Yan GX, Shimizu W, Burashnikov A: Electrical heterogeneity, the ECG, and cardiac arrhythmias. In Zipes DP, Jalife J (eds): Cardiac electrophysiology: from cell to bedside. WB Saunders Philadelphia, 1999 (in press)
49. Antzelevitch C, Shimizu W, Yan GX, Sicouri S: Cellular basis for QT dispersion. J Electrocardiol 30(suppl):168, 1998